Fuse Science, Inc. (OTCMKTS:DROP) Closes The Week Well
Fuse Science, Inc. (OTCMKTS:DROP)’s stock has been struggling to find its direction lately. The ticker has dropped almost 50% in price since the beginning of the month, however, it managed to close the past week decently.
The news that DROP will be issuing a further 13.1 million shares weren’t received that well, but the company managed to cussion the blow with a press release on Thursday and closed the week in the green.
On November 21, DROP announced that the new MacuDropTM AREDS II formula containing their technology was received with overwhelming domestic and international response at the American Academy of Ophthalmology Meeting (AAO) that took place from November 16 to November 19.
After the news, DROP opened Friday’s session gapped up at $0.0249 and gained a small increase over the course of the day, closing 16.28% up, priced at $0.025 per share. The total amount of shares that switched hands during the session was estimated at 8.8 million and generated $213 thousand in dollar volume.
Despite Friday’s success, however, DROP opened this week gapped down, with a price of $0.024 per share. The stock remains very unstable at the moment and can turn in any direction, depending on the news.
This is the exact reason for which we would advise you to do a lot of due diligence and weigh out the risks if you have any thoughts of betting on DROP.
NanoTech Entertainment, Inc. (OTCMKTS:NTEK) also recorded a decent ending of the week, gaining 10% in value. Life Stem Genetics, Inc. (OTCBB:LIFS) were not so fortunate and registered a second session in the red after the long ascent with a huge 55% loss in price.
